Mayne Pharma Group Limited - Australian Company Profile

What does Mayne Pharma Group Limited do?

Mayne Pharma is a Public Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry.

In 2024 the company generated total revenue of $397,133,000 including sales and other revenue. In 2024 Mayne Pharma had 450 employees including employees from all subsidiaries under the company's control.

The Chief Executive Officer of Mayne Pharma is either not applicable or not available.The Chairman of Mayne Pharma is Mr Frank Condella whose official title is Chair.

Mayne Pharma Group develops and manufactures branded and generic products for sale in over 20 countries. Production is managed in Greenville, North Carolina in the United States and in Salisbury, South Australia. Products include, but are not limited to: Specialty Brands Astrix capsules and tablets Doryx capsules Eryc capsules Kapanol capsules Licener single treatment Lozanoc capsules Magnoplasm paste and Magnoplasm Splintex gel Monurol Granules for Oral Solution Percutane pain relief cream Urocarb tablets Urorec CapsulesGeneric Products Aspirin tablets Caspofugin MYX Doxycycline capsules Ephedrine Hydrochloride MYX Erythromycin capsules Noradrenaline MYX Oxycodone IR tablets Water for Injection MYXAlong with production branded under the Mayne Pharma name, the company also undertakes research & development and production of pharmaceutical products on a contract basis for external companies at its Greenville facility.

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Mayne Pharma Group Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Mayne Pharma Group Limited by position type and title.

Enterprise Financials

Get a full view of Mayne Pharma Group Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Mayne Pharma Group Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Mayne Pharma Group Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Mayne Pharma Group Limited operates in.

Competitor Benchmarking

Compare Mayne Pharma Group Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Mayne Pharma Group Limited.

Subsidiaries

View a list of Mayne Pharma Group Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Mayne Pharma Group Limited, including founding information, past announcements, mergers and major projects.